Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2016 | Pages:
37 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
LegoChem Biosciences, Inc - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'LegoChem Biosciences, Inc - Product Pipeline Review - 2016', provides an overview of the LegoChem Biosciences, Inc's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by LegoChem Biosciences, Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of LegoChem Biosciences, Inc - The report provides overview of LegoChem Biosciences, Inc including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses LegoChem Biosciences, Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features LegoChem Biosciences, Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate LegoChem Biosciences, Inc's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for LegoChem Biosciences, Inc - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding LegoChem Biosciences, Inc's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 LegoChem Biosciences, Inc Snapshot 5 LegoChem Biosciences, Inc Overview 5 Key Information 5 Key Facts 5 LegoChem Biosciences, Inc - Research and Development Overview 6 Key Therapeutic Areas 6 LegoChem Biosciences, Inc - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pipeline Products - Out-Licensed Products 13 Out-Licensed Products/Combination Treatment Modalities 14 LegoChem Biosciences, Inc - Pipeline Products Glance 15 LegoChem Biosciences, Inc - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 LegoChem Biosciences, Inc - Drug Profiles 17 LCB-010699 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 LCB-030110 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 LCB-100200 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 LCB-140110 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 LCB-1414XX 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 LCB-141XXX 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibody Conjugate for Undisclosed Indication 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Recombinant Protein 1 for Cancer 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Recombinant Protein 2 for Cancer 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Recombinant Protein for Oncology 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Small Molecule to Inhibit Anaplastic Lymphoma Kinase for Oncology 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecule to Inhibit Blood Factor XIa for CAHD and Stroke 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule to Inhibit Hypoxia inducible factor-1 for Ophthalmology 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 LegoChem Biosciences, Inc - Pipeline Analysis 30 LegoChem Biosciences, Inc - Pipeline Products by Target 30 LegoChem Biosciences, Inc - Pipeline Products by Route of Administration 31 LegoChem Biosciences, Inc - Pipeline Products by Molecule Type 32 LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action 33 LegoChem Biosciences, Inc - Dormant Projects 34 LegoChem Biosciences, Inc - Locations And Subsidiaries 35 Head Office 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 36 Disclaimer 37
List of Tables
LegoChem Biosciences, Inc, Key Information 5 LegoChem Biosciences, Inc, Key Facts 5 LegoChem Biosciences, Inc - Pipeline by Indication, 2016 8 LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2016 9 LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2016 10 LegoChem Biosciences, Inc - Partnered Products in Pipeline, 2016 11 LegoChem Biosciences, Inc - Partnered Products/ Combination Treatment Modalities, 2016 12 LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2016 13 LegoChem Biosciences, Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 14 LegoChem Biosciences, Inc - Preclinical, 2016 15 LegoChem Biosciences, Inc - Discovery, 2016 16 LegoChem Biosciences, Inc - Pipeline by Target, 2016 30 LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2016 31 LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2016 32 LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2016 33 LegoChem Biosciences, Inc - Dormant Developmental Projects,2016 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
